drugset / Trial / NCT02454751

The Use of Intranasal Fentanyl for the Treatment of Incident Dyspnea in Congestive Heart Failure: A Prospective Trial

NCT02454751

Phase 2 Completed 8 enrolled St. Boniface Hospital
NaSingle-groupOpen-labelTreatment

Summary

Study Objective The primary object of this study is to investigate the safety and effectiveness of fentanyl on the management of incident dyspnea. Study Design The study design will be a cross over study with a minimum of a one hour wash out period.

Timeline

Start
2015-10
Primary completion
2017-06-30
Completion
2017-09-15

Drugs

EvaluationDrugModalityDoseRoute
Subject Fentanyl Other / unclassified 50 ug Intranasal